Why is Shree Ganesh Bio falling/rising?

As of 28-Jul, Shree Ganesh Biotech India Ltd's stock price is currently at Rs.0.79, reflecting a decrease of Rs.0.01 or 1.25%. The stock has hit a new 52-week low today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 3.66%, and it has experienced a significant drop of 24.04% year-to-date. The company is facing operational losses, a weak ability to service its debt, and a low return on equity, which collectively contribute to its negative performance. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 23.05% against the 5-day average.
In the broader market context, Shree Ganesh Biotech's performance has been notably worse than the benchmark Sensex, which has only decreased by 1.59% over the past week. The company's long-term fundamentals are weak, and it has generated a return of -35.25% over the past year, while its profits have fallen by 48%. This stark contrast to the benchmark, which has shown a positive return of 3.52% year-to-date, highlights the challenges faced by Shree Ganesh Biotech in attracting investor confidence and maintaining stock value amidst a generally more favorable market environment.